Prognostic factors in stage T1 grade 3 bladder cancer survival: The role of G1-S modulators (p53, p21Waf1, p27kip1, cyclin D1, and cyclin D3) and proliferation index (ki67-MIB1)

被引:102
作者
Lopez-Beltran, A
Luque, RJ
Alvarez-Kindelan, J
Quintero, A
Merlo, F
Carrasco, JC
Requena, MJ
Montironi, R
机构
[1] Reina Sofia Univ Hosp, Dept Pathol, Cordoba, Spain
[2] Univ Cordoba, Sch Med, E-14071 Cordoba, Spain
[3] Jaen Univ Hosp, Dept Pathol, Jaen, Spain
[4] Reina Sofia Univ Hosp, Urol Serv, Cordoba, Spain
[5] Reina Sofia Univ Hosp, Biomed Res Unit, Cordoba, Spain
[6] Polytech Univ Marche Reg Ancona, Umberto Hosp 1, Inst Pathol Anat & Histopathol, I-60020 Ancona, Italy
关键词
bladder cancer; survival; cyclin D3; cyclin D1; p27kip1; tumor size; ki67; p53; p21Waf1; stage T1;
D O I
10.1016/j.eururo.2003.11.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the prognostic value of a subset of regulators of the transition from G1-to-S phase of cell cycle in stage T1 grade 3 bladder cancers. Methods: Fifty-one such cases were investigated to determine the significance on patient's survival of p53, p21 Waf1, p27Kip1, Cyclin D1, Cyclin D3, and ki67-MIB1 (proliferation index). The statistical analysis included Kaplan-Meier methodology with Log-rank test and Cox' proportional hazard analysis. Results: Tumor size (p = 0.0034), and the labeling index of ki67-MIb1 (p = 0.0034), p53 (p = 0.0332), p27kip1 (p = 0.0059) and Cyclin D1 (p = 0.0103) were associated to disease-free survival. Progression-free survival was related to tumor size (p < 0.0001), ki67 (p = 0.0163), p53 (p = 0.0041), p27kip1 (p = 0.0161), Cyclin D1 (p < 0.0001) and Cyclin D3 (p < 0.0001). Patient's overall survival was associated to Cyclin D3 (p < 0.0001), p53 (p = 0.0017), p21Waf1 (p = 0.0142), Cyclin D1 (p < 0.0001), ki67-MIB1 (p = 0.0450), and tumor size (p = 0.0296). Down-regulation of p27kip1 and Cyclin D3 over-expression (disease-free), over-expression of p53, Cyclin D1 and Cyclin D3 (progression-free), and over-expression of Cyclin D3 (overall survival) were independent predictors by Cox's multivariate analysis. Down-regulation of p27kip1 (p < 0.001, R.R. 0.997, 95%C.I. 0.995-0.999), and over-expression of Cyclin D1 (p < 0.001, R.R. 1.009, 95%C.I. 1.004-1.014) and Cyclin D3 (p = 0.005, R.R. 1.013, 95%C.I. 1.004-1.022) were the main independent predictors. Conclusion: Down-regulation of p27kip1 and over-expression of Cyclin D1 and Cyclin D3 might be relevant predictors of survival in stage T1 grade 3 bladder cancers, thus selecting a group of patients at higher risk of malignant behavior. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:606 / 612
页数:7
相关论文
共 32 条
[21]   p53 immunohistochemistry as a prognostic marker in bladder cancer -: Playground for urology scientists? [J].
Schmitz-Dräger, BJ ;
Goebell, PJ ;
Ebert, T ;
Fradet, Y .
EUROPEAN UROLOGY, 2000, 38 (06) :691-699
[22]   Cyclin D1 expression in papillary superficial bladder cancer: Its association with other cell cycle-associated proteins, cell proliferation and clinical outcome [J].
Sgambato, A ;
Migaldi, M ;
Faraglia, B ;
De Aloysio, G ;
Ferrari, P ;
Ardito, R ;
De Gaetani, C ;
Capelli, G ;
Cittadini, A ;
Trentini, GP .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (05) :671-678
[23]  
Sgambato A, 1999, CANCER RES, V59, P3245
[24]   A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: Recurrence, progression and survival [J].
Shahin, O ;
Thalmann, GN ;
Rentsch, C ;
Mazzucchelli, L ;
Studer, UE .
JOURNAL OF UROLOGY, 2003, 169 (01) :96-100
[25]   The p53 tumor suppressor gene and nuclear protein: Basic science review and relevance in the management of bladder cancer [J].
Smith, ND ;
Rubenstein, JN ;
Eggener, SE ;
Kozlowski, JM .
JOURNAL OF UROLOGY, 2003, 169 (04) :1219-1228
[26]   Contemporary management of stage T1 transitional cell carcinoma of the bladder [J].
Soloway, MS ;
Sofer, M ;
Vaidya, A .
JOURNAL OF UROLOGY, 2002, 167 (04) :1573-1583
[27]   The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer [J].
Solsona, E ;
Iborra, I ;
Dumont, R ;
Rubio-Briones, J ;
Casanova, J ;
Almenar, S .
JOURNAL OF UROLOGY, 2000, 164 (03) :685-689
[28]   Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials [J].
Sylvester, RJ ;
van der Meijden, APM ;
Lamm, DL .
JOURNAL OF UROLOGY, 2002, 168 (05) :1964-1970
[29]  
Wagner U, 1999, J PATHOL, V188, P44, DOI 10.1002/(SICI)1096-9896(199905)188:1<44::AID-PATH320>3.0.CO
[30]  
2-Q